Skip to main content

Table 5 Multivariate analysis for overall survival including primary tumour extension

From: Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma

Marker

Hazard Ratio

95% CI

P

Sex

1,185

0,49–2.83

0.702

Age

1.108

0.93–1.13

0.390

Breslow thickness

2.530

1.62–3.94

< 0.001

CMC status (0–1 vs ≥2 positive assays)

2.685

1.17–6.49

0.026

  1. CI, confidence interval
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us